August 2017 - Volume 28 - Issue 7 - Contributor Index

Alphabetical Search
O
U
Author:
Aouad, Patrick
Author:
Bar-Sela, Gil
Author:
Can, Zhou
Author:
Catane, Raphael

Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer: a retrospective cohort study with a comparative analysis of toxicity and survival

Tahover, Esther; Segal, Amiel; Isacson, Rut; More

Anti-Cancer Drugs . 28(7):787-794, August 2017.

Author:
Chen, Yan
Author:
Chenchen, Jiang
Author:
Cherny, Nathan

Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer: a retrospective cohort study with a comparative analysis of toxicity and survival

Tahover, Esther; Segal, Amiel; Isacson, Rut; More

Anti-Cancer Drugs . 28(7):787-794, August 2017.

Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer

Stahler, Arndt; Heinemann, Volker; Neumann, Jens; More

Anti-Cancer Drugs . 28(7):717-722, August 2017.

Author:
Fang, Jun

Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer

Stahler, Arndt; Heinemann, Volker; Neumann, Jens; More

Anti-Cancer Drugs . 28(7):717-722, August 2017.

Author:
Fostok, Sabreen

Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer: a retrospective cohort study with a comparative analysis of toxicity and survival

Tahover, Esther; Segal, Amiel; Isacson, Rut; More

Anti-Cancer Drugs . 28(7):787-794, August 2017.

Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer

Stahler, Arndt; Heinemann, Volker; Neumann, Jens; More

Anti-Cancer Drugs . 28(7):717-722, August 2017.

Author:
Gips, Maya

Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer: a retrospective cohort study with a comparative analysis of toxicity and survival

Tahover, Esther; Segal, Amiel; Isacson, Rut; More

Anti-Cancer Drugs . 28(7):787-794, August 2017.

Author:
Grenader, Tal

Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer: a retrospective cohort study with a comparative analysis of toxicity and survival

Tahover, Esther; Segal, Amiel; Isacson, Rut; More

Anti-Cancer Drugs . 28(7):787-794, August 2017.

Author:
Haas, Michael

Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer

Stahler, Arndt; Heinemann, Volker; Neumann, Jens; More

Anti-Cancer Drugs . 28(7):717-722, August 2017.

Author:
Hassoun, Gamal
Author:
He, Jing

Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer: a retrospective cohort study with a comparative analysis of toxicity and survival

Tahover, Esther; Segal, Amiel; Isacson, Rut; More

Anti-Cancer Drugs . 28(7):787-794, August 2017.

Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer

Stahler, Arndt; Heinemann, Volker; Neumann, Jens; More

Anti-Cancer Drugs . 28(7):717-722, August 2017.

Author:
Hiramoto, Akiko

Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer

Stahler, Arndt; Heinemann, Volker; Neumann, Jens; More

Anti-Cancer Drugs . 28(7):717-722, August 2017.

Author:
Hu, Jingyu
Author:
Isacson, Rut

Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer: a retrospective cohort study with a comparative analysis of toxicity and survival

Tahover, Esther; Segal, Amiel; Isacson, Rut; More

Anti-Cancer Drugs . 28(7):787-794, August 2017.

Author:
Jung, Andreas

Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer

Stahler, Arndt; Heinemann, Volker; Neumann, Jens; More

Anti-Cancer Drugs . 28(7):717-722, August 2017.

Author:
Kim, Hye-Sook

Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer

Stahler, Arndt; Heinemann, Volker; Neumann, Jens; More

Anti-Cancer Drugs . 28(7):717-722, August 2017.

Author:
Kruger, Stephan

Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer

Stahler, Arndt; Heinemann, Volker; Neumann, Jens; More

Anti-Cancer Drugs . 28(7):717-722, August 2017.

Author:
Lele, Song
Author:
Lingling, Liu
Author:
Liu, Hao
Author:
Matsuda, Akira
Author:
Mesika, Lior

Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer: a retrospective cohort study with a comparative analysis of toxicity and survival

Tahover, Esther; Segal, Amiel; Isacson, Rut; More

Anti-Cancer Drugs . 28(7):787-794, August 2017.

Author:
Michl, Marlies

Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer

Stahler, Arndt; Heinemann, Volker; Neumann, Jens; More

Anti-Cancer Drugs . 28(7):717-722, August 2017.

Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer

Stahler, Arndt; Heinemann, Volker; Neumann, Jens; More

Anti-Cancer Drugs . 28(7):717-722, August 2017.

Author:
Muñoz, Miguel
Author:
Naito, Tomoharu
Author:
Neumann, Jens

Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer

Stahler, Arndt; Heinemann, Volker; Neumann, Jens; More

Anti-Cancer Drugs . 28(7):717-722, August 2017.

Author:
Pei, Zhang
Author:
Pisano, Claudio
Author:
Qiong, Pan

Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer

Stahler, Arndt; Heinemann, Volker; Neumann, Jens; More

Anti-Cancer Drugs . 28(7):717-722, August 2017.

Author:
Roditis, Pavlos
Author:
Rose, Peter G.

Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer: a retrospective cohort study with a comparative analysis of toxicity and survival

Tahover, Esther; Segal, Amiel; Isacson, Rut; More

Anti-Cancer Drugs . 28(7):787-794, August 2017.

Author:
Ruan, Jun
Author:
Saikali, Melody
Author:
Saji, Hisashi
Author:
Sakai, Hiroki
Author:
Sato, Akira
Author:
Savoia, Paola

Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer

Stahler, Arndt; Heinemann, Volker; Neumann, Jens; More

Anti-Cancer Drugs . 28(7):717-722, August 2017.

Author:
Segal, Amiel

Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer: a retrospective cohort study with a comparative analysis of toxicity and survival

Tahover, Esther; Segal, Amiel; Isacson, Rut; More

Anti-Cancer Drugs . 28(7):787-794, August 2017.

Author:
Stahler, Arndt

Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer

Stahler, Arndt; Heinemann, Volker; Neumann, Jens; More

Anti-Cancer Drugs . 28(7):717-722, August 2017.

Author:
Stauch, Martina

Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer

Stahler, Arndt; Heinemann, Volker; Neumann, Jens; More

Anti-Cancer Drugs . 28(7):717-722, August 2017.

Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer

Stahler, Arndt; Heinemann, Volker; Neumann, Jens; More

Anti-Cancer Drugs . 28(7):717-722, August 2017.

Author:
Surong, Zhao
Author:
Tahover, Esther

Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer: a retrospective cohort study with a comparative analysis of toxicity and survival

Tahover, Esther; Segal, Amiel; Isacson, Rut; More

Anti-Cancer Drugs . 28(7):787-794, August 2017.

Author:
Takano, Takeshi
Author:
Talhouk, Rabih
Author:
Téllez, Teresa
Author:
Turgeman, Ilit
1 2 Next